4HAN M, LIU Y, TAN Q I, et al. Therapeutic efficacy of stemazole in a beta amyloid injection rat model of Alzheimer's disease[J]. Eur J Pharmacol, 2011,657(1-3) :104-110.
5ISMAEL SANTA-MARA-A, HERNAINDEZ F, FRANCISCO J M, et al. Taurine, an inducer for tau polymerization and a weak inhihitor for amyloid-I^2-peptide aggregation[J]. Neurosci Lett, 2007,429(2-3) :91-94.
6ROSEMBERG D B, DA ROCHA R F, RICO E P, et al. Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain [J]. Neuroscience, 2010,171 (3) : 683-692.
7GIOVANNEIAA L, SCALA C, FAUSSONE-PELLEGRINI M S, et al. Long-term changes in the aggregation state and toxic effects of beta amyloid iniected into the rat brain[J]. Neuroscience, 1998,87(2):349-357.
8CAPPAI R, BARNHAM K J. Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity[J]. Neurochem Res, 2008,33(3):526-532.
9WALLACE T L, PORTER R H. Targeting the nicotinic alpha7 acetyleholine receptor to enhance cognition in disease[J].Biochem Pharmacol, 2011,82(8) :891-903.
10GIOVANNELLI L, CASAMENTI F, SCALI C, et al. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35)injections into the rat nucleus basalis[J]. Neuroscience, 1995, 66(4) :781-792.
